Sr. No. 

Title of Project

Proposal No. (IEC No.) 

Name of Principle Investigator

Amount of Grant Received

Name of Funding Agency

Collaboration with other

 institute (if any)

Status of Project (Ongoing/ Completed)

Publication (YES/NO)

Allopurinol for CVD in CKD (AvoiD-CKD): A double blind, randomized controlled trial

IEC/Pharmac/2023/651

Dr. Anand Chellappan

(Site PI)

51,800/-

ICMR

(PGIMER, Chandigarh-Main Site)

-

Completed

No

Sr. No. 

Title of Project

Proposal No. (IEC No.) 

Name of Principle Investigator

Amount of Grant Received

Name of Funding Agency

Collaboration with other

 institute (if any)

Status of Project (Ongoing/ Completed)

Publication (YES/NO)

Comparison of Nephrologist versus Artificial Intelligence/Machine learning based assessment of Dry weight and the impact on clinical outcomes in Adult End stage kidney disease patients on hemodialysis

IEC/Pharmac/2024/942

Dr. Anand Chellappan

4.5L

Indian Society of Nephrology(ISN) La Renon Research Grant

VNIT, Nagpur

Ongoing

Yes

Metformin therapy in polycystic Kidney Disease : A randomized, controlled trial.

IEC/Pharmac/2024/1015

Dr. Amol Bhawane

(Site PI)

ICMR

(PGIMER, Chandigarh-Main Site)

PGI Chandigarh

Ongoing

No

Sr. No. 

Title of Project

Proposal No. (IEC No.) 

Name of Principle Investigator

Amount of Grant Received

Name of Funding Agency

Collaboration with other

 institute (if any)

Status of Project (Ongoing/ Completed)

Publication (YES/NO)

Comparison of Nephrologist versus Artificial Intelligence/Machine learning based assessment of Dry weight and the impact on clinical outcomes in Adult End stage kidney disease patients on hemodialysis

IEC/Pharmac/2024/942

Dr. Anand Chellappan

4.5L

Indian Society of Nephrology(ISN) La Renon Research Grant

VNIT, Nagpur

Ongoing

Yes

Sr. No.

Title of Project

Clinical Trial No. 

Name of Principle Investigator

Amount Received

Sponsors

Status of Project (Ongoing/ Completed)

Publication (YES/NO)

Controlled evaluation of Angiotensin Receptor Blockers for COVID-19 respiratory disease (CLARITY)

CTRI/2020/07/026831

Dr. Anand Chellappan

George Institute for Global Health

Completed

No

A two-year, phase III randomized, double-blind, parallel-group, placebo controlled trial to evaluate the safety, efficacy, tolerability of 300mg s.c secukinumab versus placebo, in combination with SoC therapy, in patients with active lupus nephritis

IECCT/Pharmac/2023/224

Dr Anand Chellappan

Novartis

Terminated by sponsor

No

A Novel High-fidelity Reproduciable Traning Model for Ultrasound guided percutaneous Peritoneal Dialysis catheter Insetion Using a soft-Embalmed Cadaver: Retrospective Ealuation and prospective Framework for Educational Research

IEC/Pharmac/2025/1508

Dr. Anand Chellappan

 No

 Ongoing

 No

Clinical Spectrum and Feto-maternal Outcomes in pregnancy – Related Acute Kidney Injury: A natiowide study.

IEC/Pharmac/2025/1685

Dr. Anand Chellappan

AIIMS Bhubaneshwar

Ongoing

Yes

Sr. No.

Title of Project

Proposal No. (IEC No.)

Name of Principle Investigator

Status of Project (Ongoing/ Completed)

Publication (YES/NO)

Utility of Reticulocyte Hemoglobin equivalent (RET-He) and percentage of hypochromic RBCs (%HRC) as markers of Iron deficiency anemia among chronic kidney disease patients (ICMR STS)

IEC/Pharmac/2023/656

Ms Gouri Lahoti

Dr Anand Chellappan

Completed

No

To examine prescription patterns for arrhythmogenic drugs in hemodialysis patients and conduct electrocardiography evaluations. (ICMR STS)

IEC/Pharmac/2023/663

Ms Awanti Meshram

Dr Amol Bhawane

Completed

No

Comparison of Routine office blood pressure measurement versus standardized attended Oscillometric blood pressure measurement in patients with chrionic kidney disease. (ICMR STS)

IEC/Pharmac/2022/436

Ms. Keshiha Kansal

Dr. Anand Chellappan

Completed

Published

Geographical Distribution of chronic kidney Diasese (CKD) and Chronic kidney  Diasese of Unknown origin (CKDu) in the central India Population

IEC No : IEC/Pharmac/2025/1770

Sidhharth Singla

Dr. Manoj Dhanorkar

Ongoing

No

Clinico-Pathological Features, Epidemiology and Short-term Outcomes of Proliferative Lupus Nephritis at a Tertiary Care Center in Central India

IEC No : IEC/Pharmac/2024/1005

(PG Thesis)

Dr. Asmita Urade Sanjay

Dr. Anand Chellappan

Ongoing

No

Validation of Urinary Soluble CD163 as a Biomarker for Lupus Nephritis Disease Activity Among Adult Patients with Systemic Lupus Erythematosus Presenting to a Tertiary Care Centre in Central India

IEC No : IEC/Pharmac/2025/1542

(PG Thesis)

Dr Sakshi Mittal

Dr. Anand Chellappan

Ongoing

No

A Comparative analysis and short term outcome of glucose-free and glucose-containing dialysate: A prospective crossover study in maintenance hemodialysis patients.

IEC No : IEC/Pharmac/2025/1332

(PG Thesis)

Dr Pankaj Behera

Dr. Amol Bhawane 

Ongoing

No

Profile and Treatment Outcomes of Patients with Membranous Nephropathy

IEC No : IEC/Pharmac/2024/819

(PG Thesis)

Dr. Jwala K. A.

Completed

No

Exploring The Efficacy And Safety Of Dapagliflozin In Slowing Chronic Kidney Disease Progression: A Study Focusing On Egfr And Albuminuria In Central Indian Cohort

IEC No : IEC/Pharmac/2024/1023

(PG Thesis)

Dr. Ravi Kumar Meena

Ongoing

No

Efficacy and Safety of Plasma Filter Reuse in Membrane-Based Plasmapheresis using Dialyzer Reprocessing System: A Prospective Clinical Study

IEC No : IEC/Pharmac/2025/1686

(PG Thesis)

Dr. Akshita Gupta

Dr. Manoj Dhanorkar

Ongoing

No

S. No.

Publications

Year

Impact factor

1.       

Sharma S, Kute V, Chellappan A, Bajpai D, Balwani M, Sahay M, Prasad N. Social media coverage of the 32nd Annual Conference of the Indian Society of Organ Transplantation 2022: Unity in diversity. Indian Journal of Transplantation. 2023;17(2):233–235. doi:10.4103/ijot.ijot_20_23.

2023

0.2

2.       

Srivastava A, Choudhary S, Chellappan A, Choudhary R. Necrotic skin lesion as the first manifestation of IgA vasculitis with nephritis. BMJ Case Rep. 2023;16(11):e255823. doi:10.1136/bcr-2023-255823.

2023

0.5

3.       

Nikhil John E, Chellappan A, Ghodeshwar G, Sharma A, Chaudhari SR. Acute myocardial infarction in a patient with focal segmental glomerulosclerosis tip lesion: Hit with a double whammy. Cureus. 2023;15(11):e48860. doi:10.7759/cureus.48860.

2023

-

4.       

Pasari AS, Balwani MR, Gurjar P, Bawankule C, Bhawane A, Tolani P, Kashiv P, Dubey S, Katekhaye VM. CYP3A5 Polymorphism in Renal Transplantation: A Key to Personalized Immunosuppression. InTransplantation Proceedings 2023 Mar 25. Elsevier.(original article)

2023

0.8

5.       

Balwani MR, Pasari AS, Gurjar P, Bhawane A, Bawankule C, Tolani P, Kashiv P, Dubey S, Katekhaye VM. Profile and Post-Kidney Retrieval Outcomes in Asymptomatic Kidney Donors With Genetic Mutations in Complement Factors–Related Genes. InTransplantation Proceedings 2023 Mar 27. Elsevier.(original article)

2023

0.8

6.       

Balwani MR, Pasari AS, Gurjar P, Bhawane A, Bawankule C, Tolani P, Kashiv P, Dubey S, Katekhaye VM. Kidney Transplant Outcomes in Patients with Atypical Hemolytic Uremic Syndrome. InTransplantation Proceedings 2023 May 16. Elsevier.(original article)

2023

0.8

7.       

Balwani MR, Pasari AS, Bawankule C, Bhawane A, Tolani P, Katekhaye VM. Humoral Response After Two Doses of COVISHIELD TM Vaccine in Patients Undergoing Maintenance Hemodialysis. The Journal of the Association of Physicians of India. 2023 Sep 1;71(9):56-60. (original article)

2023

-

8.       

Balwani MR, Pasari AS, Bawankule C, Bhawane A, Tolani P, Katekhaye VM. ABO Incompatible Kidney Transplant in a Patient With Atypical Hemolytic Uremic Syndrome: Case Report. InTransplantation Proceedings 2023 Oct 1 (Vol. 55, No. 8, pp. 1913-1916). Elsevier. (case report)

2023

0.8

9.       

Chellappan A, Bhawane A, Sharma A, et al. IgG4-related kidney disease: A diagnostic conundrum successfully treated with steroids and rituximab. Cureus. 2024;16(1):e52000. doi:10.7759/cureus.52000.

2024

-

10.   

Chellappan A, Kansal K. Comparison of routine office blood pressure measurement versus standardized attended manually activated oscillometric office blood pressure measurement in patients with chronic kidney disease. J Family Med Prim Care. 2024;13(5):1894–1903. doi:10.4103/jfmpc.jfmpc_1619_23.

2024

1

11.   

Prasad N, Meyyappan J, Dhanorkar M, Kushwaha R, Mandal K, Veeranki V, Behera M, Patel M, Yadav B, Bhadauria D, Kaul A, Yaccha M, Bhatt M, Agarwal V, Jain M. Novel mutation patterns in children with steroid-resistant nephrotic syndrome. Clin Kidney J. 2024;17(8):sfae218. doi:10.1093/ckj/sfae218. PMID:39135934; PMCID:PMC11317842.

2024

4.6

12.   

Pasari A, Balwani M, Gurjar P, Sejpal K, Bawankule C, Tolani P, Dubey S, Kashiv P, Bhawane A, Malde S, Gupta S. A Rare Case of Autoimmune Disorder as a Trigger for Atypical Hemolytic Uremic Syndrome. Cureus. 2024 Jan 28;16(1):e53126. doi: 10.7759/cureus.53126. PMID: 38420105; PMCID: PMC10899531.(case report)

2024

-

13.   

Chellappan A, Bhawane A, Sharma A, Rokade R. IgG4-Related Kidney Disease: A Diagnostic Conundrum Successfully Treated With Steroids and Rituximab. Cureus. 2024 Jan 10;16(1):e52000. doi: 10.7759/cureus.52000. PMID: 38344630; PMCID: PMC10853830.(case report)

2024

-

14.   

Balwani MR, Pasari A, Bawankule C, Bhawane A, Tolani P, Katekhaye V. Incidental severe hyponatremia with use of isabgol: A rare case. Turk J Nephrol. 2024;33(1):116-117.(case report)

2024

0.2

15.   

Balwani M, Pasari A, Gurjar P, Sejpal K, Bawankule C, Tolani P, Dubey S, Kashiv P, Bhawane A, Malde S, Gupta S. BortezomibInduced Superficial Vasculitis in a Kidney Transplant Recipient: A Rare Case. Cureus. 2024 Apr;16(4). (case report)

2024

-

16.   

Pasari A, Balwani M, Bawankule C, Tolani P, Gurjar P, Sejpal K, Malde S, Gupta S, Dubey S, Kashiv P, Bhawane A. DapagliflozinInduced Erythrocytosis in Chronic Kidney Disease: A Rare Occurrence. Cureus. 2024 Apr;16(4). (case report)

2024

-

17.   

Kashiv P, Malde S, Dubey S, Gupta S, Pawar T, Sejpal KN, Gurjar P, Pasari A, Balwani M, Bhawane A, Tolani P. A Case of Erythropoietin (EPO)-Induced Pure Red Cell Aplasia and Its Treatment Efficacy With Desidustat. Cureus. 2024 Jun;16(6). (case report)

2024

-

18.   

Kashiv P, Dubey S, Malde S, Gupta S, Pawar T, Sejpal KN, Gurjar P, Bhawane A, Tolani P, Bawankule CP, Pasari A. A Rare Case of Carpenter Syndrome and Its Unique Association With Chronic Kidney Disease. Cureus. 2024 Jun;16(6). (case report)

2024

-

19.   

Dhanorkar MA, Rao S N, Malhotra KP, Ansari M, Chandra A. Novel NUP93 gene variant and diffuse mesangial sclerosis in steroid resistant nephrotic syndrome. Indian Journal of Pediatrics. 2024 May;91(5):517-.

2024

2.0

20.   

Sarkar M, Chellappan A, Choudhary A, Dhanorkar MA. Novel TRPV4 gene mutation and diffuse mesangial sclerosis in steroid-resistant nephrotic syndrome. Indian J Nephrol. 2025;35:580–581. doi:10.25259/IJN_808_2024.

2024

0.8

21.   

Ansari M, Dhanorkar MA, Rao NS, Chandra A. A Case of Maggot Infestation in a Tunneled Hemodialysis Catheter: An Unusual Presentation. Indian Journal of Nephrology. 2025 Apr 25;35(3):439.

2025

0.8

22.   

Poddar A, Chellappan A, Gade N, Sarkar M, Mishra M. A rare case of infective endocarditis caused by Kodamaea ohmeri. Journal of Laboratory Physicians. 2025;17:284–287. doi:10.25259/JLP_315_2024.

2025

1

23.   

Gupta A, Deshpande V, Kimmatkar P, Chellappan A. Anti-GBM disease without antibodies after H1N1 infection: Seronegative or atypical? Journal of Laboratory Physicians. 2025; Letter to the Editor. doi:10.25259/JLP_259_2025.

2025

1

24.   

Bansal SB, Lokkur PP, Subhash S, Subbiah A, Sethi SK, Chellappan A, et al. Anemia of chronic kidney disease in India: Consensus guidelines of the Indian Society of Nephrology. Indian J Nephrol. 2025;35(Suppl 1):S1–S31. doi:10.25259/IJN_156_2025.

2025

0.8

25.   

Jayachandran M, B.C. R, Choudhary A, Chellappan A et al. FSGS in Kimura disease – A rare cause of nephrotic syndrome in an adolescent. Indian J Pediatr. 2025;92:666. doi:10.1007/s12098-025-05509-7.

2025

2

26.   

Sarkar M, Chellappan A, Choudhary A, Dhanorkar MA. Novel TRPV4 gene mutation and diffuse mesangial sclerosis in steroid-resistant nephrotic syndrome. Indian J Nephrol. 2025;35:580–581. doi:10.25259/IJN_808_2024.

2025

0.8